Comparison of Usefulness of Body Mass Index Versus Metabolic Risk Factors in Predicting 10-year Risk of Cardiovascular Events in Women

Overview

Journal Am J Cardiol

Specialty Cardiology & Vascular Diseases

Date 2007 Nov 27

PMID 18036364

Citations 49

Authors

Yiqing Song

JoAnn E Manson

James B Meigs

Paul M Ridker

Julie E Buring

Simin Liu

Affiliations

Soon will be listed here.

Abstract

The objective of this study was to prospectively examine the comparative importance of body mass index (BMI) and metabolic syndrome (MS) related risk factors in predicting future risk of cardiovascular disease (CVD) in women. Of 25,626 women aged>or=45 years and free of CVD, cancer, and diabetes at baseline in the Women's Health Study, all women were classified into 6 groups according to 3 BMI categories (<25, 25 to 29.9, and >or=30 kg/m2) and the presence or absence of MS, defined using modified criteria of the National Cholesterol Education Program Adult Treatment Program III. During a median 10-year follow-up, 724 incident CVD events were documented. Compared with lean women without MS, multivariate relative risks of CVD, adjusting for age, physical activity, and other covariates, were 2.40 (95% confidence interval [CI] 1.71 to 3.37) for lean women who had MS, 1.08 (95% CI 0.87 to 1.33) for overweight women who had no MS, 3.01 (95% CI 2.30 to 3.94) for overweight women with MS, 1.58 (95% CI 1.21 to 2.08) for obese women without MS, and 2.89 (95% CI 2.19 to 3.80) for obese women with MS. Similar associations were evident for total coronary heart disease, but were not significant for total stroke. Overall, although C-reactive protein added additional prognostic information beyond BMI and MS, it did not fully account for the observed high risk of CVD associated with MS. In conclusion, MS may largely account for the increased risk of CVD associated with BMI in apparently healthy women.

Citing Articles

The relationship between body mass index and pathological complete response in Brazilian breast cancer patients.

Richter F, Mattar A, Antonini M, Teixeira M, Amorim A, Millen E Sci Rep. 2025; 15(1):6174.

PMID: 39979484 PMC: 11842549. DOI: 10.1038/s41598-025-89841-0.

Lipid accumulation product is an effective predictor of metabolic syndrome in non-obese women with polycystic ovary syndrome.

Han W, Zhang M, Wang H, Yang Y, Wang L Front Endocrinol (Lausanne). 2024; 14:1279978.

PMID: 38269246 PMC: 10807289. DOI: 10.3389/fendo.2023.1279978.

Risk of Stroke Among Different Metabolic Obesity Phenotypes: A Systematic Review and Meta-Analysis.

Meng M, Guo Y, Kuang Z, Liu L, Cai Y, Ni X Front Cardiovasc Med. 2022; 9:844550.

PMID: 35548434 PMC: 9081493. DOI: 10.3389/fcvm.2022.844550.

Differential Genetic and Epigenetic Effects of the Gene on Body Shape Indices and Metabolic Traits.

Wu S, Hsu L, Teng M, Chou H, Ko Y Int J Mol Sci. 2022; 23(8).

PMID: 35456983 PMC: 9032945. DOI: 10.3390/ijms23084165.

Body Mass Index and Long-Term Follow-Up Outcomes in Patients With Acute Myocardial Infarction by the Median of Non-HDL Cholesterol: Results From an Observational Cohort Study in China.

Gao H, Shen A, Chen H, Li H Front Cardiovasc Med. 2021; 8:750670.

PMID: 34869654 PMC: 8634779. DOI: 10.3389/fcvm.2021.750670.

References

Ford E . The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis. 2004; 173(2):309-14. DOI: 10.1016/j.atherosclerosis.2003.12.022. View

Ridker P, Buring J, Cook N, Rifai N . C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003; 107(3):391-7. DOI: 10.1161/01.cir.0000055014.62083.05. View

Festa A, DAgostino Jr R, Howard G, Mykkanen L, Tracy R, Haffner S . Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000; 102(1):42-7. DOI: 10.1161/01.cir.102.1.42. View

Song Y, Manson J, Buring J, Liu S . A prospective study of red meat consumption and type 2 diabetes in middle-aged and elderly women: the women's health study. Diabetes Care. 2004; 27(9):2108-15. DOI: 10.2337/diacare.27.9.2108. View

Rexrode K, Lee I, Cook N, Hennekens C, Buring J . Baseline characteristics of participants in the Women's Health Study. J Womens Health Gend Based Med. 2000; 9(1):19-27. DOI: 10.1089/152460900318911. View

Ridker P, Rifai N, Rose L, Buring J, Cook N . Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002; 347(20):1557-65. DOI: 10.1056/NEJMoa021993. View

Atiya M, Kurth T, Berger K, Buring J, Kase C . Interobserver agreement in the classification of stroke in the Women's Health Study. Stroke. 2003; 34(2):565-7. DOI: 10.1161/01.str.0000054159.21017.7c. View

Sattar N, Gaw A, Scherbakova O, Ford I, OReilly D, Haffner S . Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation. 2003; 108(4):414-9. DOI: 10.1161/01.CIR.0000080897.52664.94. View

Rexrode K, Buring J, Manson J . Abdominal and total adiposity and risk of coronary heart disease in men. Int J Obes Relat Metab Disord. 2001; 25(7):1047-56. DOI: 10.1038/sj.ijo.0801615. View

10.

Meigs J, Wilson P, Fox C, Vasan R, Nathan D, Sullivan L . Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab. 2006; 91(8):2906-12. DOI: 10.1210/jc.2006-0594. View

11.

Katzmarzyk P, Church T, Janssen I, Ross R, Blair S . Metabolic syndrome, obesity, and mortality: impact of cardiorespiratory fitness. Diabetes Care. 2005; 28(2):391-7. DOI: 10.2337/diacare.28.2.391. View

12.

Goodpaster B, Krishnaswami S, Harris T, Katsiaras A, Kritchevsky S, Simonsick E . Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch Intern Med. 2005; 165(7):777-83. DOI: 10.1001/archinte.165.7.777. View

13.

Ridker P, Cook N, Lee I, Gordon D, Gaziano J, Manson J . A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005; 352(13):1293-304. DOI: 10.1056/NEJMoa050613. View

14.

Santos A, Lopes C, Guimaraes J, Barros H . Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome. Int J Obes (Lond). 2005; 29(12):1452-6. DOI: 10.1038/sj.ijo.0803035. View

15.

Manson J, Willett W, Stampfer M, Colditz G, Hunter D, Hankinson S . Body weight and mortality among women. N Engl J Med. 1995; 333(11):677-85. DOI: 10.1056/NEJM199509143331101. View

16.

Lakka H, Laaksonen D, Lakka T, Niskanen L, Kumpusalo E, Tuomilehto J . The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002; 288(21):2709-16. DOI: 10.1001/jama.288.21.2709. View

17.

Park Y, Zhu S, Palaniappan L, Heshka S, Carnethon M, Heymsfield S . The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003; 163(4):427-36. PMC: 3146257. DOI: 10.1001/archinte.163.4.427. View

18.

Kip K, Marroquin O, Kelley D, Johnson B, Kelsey S, Shaw L . Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation. 2004; 109(6):706-13. DOI: 10.1161/01.CIR.0000115514.44135.A8. View

19.

Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna R . Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. Diabetes Care. 2003; 26(4):1251-7. DOI: 10.2337/diacare.26.4.1251. View